Warfarin in vulnerable older adults with atrial fibrillation.
Gharacholou
S Michael
SM
Division of Cardiology, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27715, USA.
Becker
Richard C
RC
D000367:Age Factors; D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced / Q000209:etiology; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D014859:Warfarin